Can You Switch Back to Mounjaro After Foundayo?

Written byDr Amel Imam MBBS, MRCGP, BMSGP / Medical Director GMC No. 7031310
Reviewed by Dr Mohamed ObiedallaMPharm, MBA, PhD, MRCPharmSuperintendent Pharmacist GPhC No. 2061908
Published
Last reviewed Our clinical review process
Can You Switch Back to Mounjaro After Foundayo?

If you have switched from Mounjaro to Foundayo, one understandable question is:

“What happens if Foundayo doesn’t suit me - can I go back to Mounjaro?”

Yes, following an appropriate clinical assessment.

Changing treatment does not mean making an irreversible decision.

Why might someone want to switch back to Mounjaro?

Foundayo and Mounjaro are different medicines, so it is reasonable to find that one treatment suits you better than another.

You may notice differences in:

  • appetite suppression
  • hunger
  • food cravings or “food noise”
  • feelings of fullness
  • gastrointestinal side effects
  • weight stability
  • how the dosing routine fits into everyday life

Some patients may prefer the convenience of a daily tablet.

Others may find that they preferred their experience with weekly Mounjaro.

Neither response is wrong.

What is the difference between Foundayo and Mounjaro?

Foundayo contains orforglipron, a GLP-1 receptor agonist taken once daily.

Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors and is administered once weekly.

There is therefore no simple dose for dose conversion between the two medicines.

Can I simply restart my previous Mounjaro dose?

Not necessarily.

Your clinician needs to consider factors such as:

  • your previous Mounjaro dose
  • how long you were established on it
  • how well you tolerated treatment
  • how long it has been since your last Mounjaro injection
  • your current Foundayo dose
  • how long you have been taking Foundayo
  • current side effects
  • current weight and appetite
  • other medication
  • your wider medical history

This is why restarting should be an individual prescribing decision.

Why does the treatment gap matter?

Tolerance to incretin-based medicines develops over time.

After a longer interruption, restarting a previous high Mounjaro dose may not be appropriate because your previous level of tolerability cannot automatically be assumed.

The longer you have been away from Mounjaro, the more cautious the restart may need to be.

This helps reduce the risk of side effects such as:

  • nausea
  • vomiting
  • diarrhoea
  • constipation
  • abdominal discomfort

Your previous Mounjaro dose is therefore only one part of the decision.

What if Foundayo does not control my appetite as well?

It can take time to adjust after changing treatments.

A short-term change in appetite does not automatically mean Foundayo is unsuitable.

However, it is worth reviewing treatment if you notice a sustained pattern of:

  • increasing hunger
  • increasing food noise
  • difficulty controlling portions
  • recurring cravings
  • meaningful weight regain over several weeks
  • Weight maintenance should be judged on the overall trend, rather than one day of increased hunger or one
  • higher reading on the scales.

What if I am gaining weight?

Some normal fluctuation is expected during maintenance.

One higher weight does not automatically mean you need to change medication.

We are more interested in a consistent trend.

If weight is steadily increasing alongside greater hunger or food cravings, your clinician can review whether to:

  • remain on Foundayo for longer
  • adjust the Foundayo dose
  • review nutrition and activity
  • consider another treatment
  • potentially return to Mounjaro

Can I take Foundayo and Mounjaro together while switching?

You should not combine or overlap these medicines unless specifically instructed to do so by your prescribing clinician.

A clinically managed switch should give you clear instructions about:

  • when to stop Foundayo
  • when to begin Mounjaro
  • what Mounjaro dose is appropriate
  • what symptoms to monitor

This helps reduce unnecessary side effect risk and keeps the transition as safe as possible.

Switching treatment is not a failure

Trying Foundayo and later deciding that Mounjaro suits you better does not mean either you or the treatment has failed.

Weight management medicine is increasingly about personalising treatment over the long term.

What works during active weight loss may not be what works best for weight maintenance.

Similarly, your preferences and needs can change.

How Pharmulous can help

At Pharmulous, we do not believe patients should feel locked into one medication or one rigid pathway.

If Foundayo is not meeting your needs, our clinicians can review the situation with you.

Rather than simply looking at the name of the medicine or your current dose, we take a holistic view of:

  • your previous treatment
  • how you responded
  • your current weight trajectory
  • appetite and food noise
  • side effects
  • treatment gaps
  • wider medical history
  • your maintenance goals

Our approach is:

Flexible - treatment can be reviewed and changed when clinically appropriate.

Maintenance friendly - we understand that long-term treatment may need to evolve after weight loss.

Holistic - we consider the whole clinical picture rather than focusing on a single dose or BMI.

Patient centred - your experience of treatment and your preferences matter.

Clinically safe - flexibility does not mean automatically approving every switch. Safety, tolerability and suitability remain central to prescribing.

Supported - if you change treatment and your appetite, weight or side effects change afterwards, our clinical team can review the plan with you.

If staying on Foundayo remains the best option, we will tell you.

If adjusting the dose may be appropriate, that can be reviewed.

And if returning to Mounjaro is clinically appropriate, we can help you do this in a way that takes your previous treatment and treatment gap into account.

Being patient centred does not mean saying yes to every treatment request.

It means listening to your experience, considering the whole clinical picture and helping you make the safest appropriate decision for you.

Frequently asked questions

Can I go back to Mounjaro after Foundayo?

Potentially, yes. Suitability and the appropriate starting dose need to be assessed by a prescriber.

Will I restart at my old Mounjaro dose?

Not necessarily. The time since your last Mounjaro injection and your treatment history are important.

What if I have only taken Foundayo for a short time?

Your clinician can still review whether continuing or changing treatment is appropriate.

Does switching back mean Foundayo failed?

No. Weight management treatment is individual, and some medicines simply suit certain patients better than others.

Can I switch medicines myself?

No. Switching prescription GLP-1 medicines should be clinically supervised.

Key takeaway

Switching back to Mounjaro after Foundayo may be possible, but it should not be done by simply restarting your old injection strength.

Your previous treatment, how long you have been away from Mounjaro, tolerability and current clinical circumstances all need to be considered.

Treatment should be able to change as your needs change — safely, flexibly and with appropriate clinical support.

References

  1. Mounjaro (tirzepatide) UK Summary of Product Characteristics, electronic Medicines Compendium.
  2. Foundayo (orforglipron) UK Summary of Product Characteristics, electronic Medicines Compendium.
  3. Pharmulous. Switching From Mounjaro to Foundayo.
  4. Aronne LJ et al. Orforglipron for maintenance of body weight reduction: the double-blind, randomized Phase
  5. 3b ATTAIN-MAINTAIN trial. Nature Medicine, 2026.

Sign up to our newsletter

Sign up to be the first to know about promotions and news.